Company Filing History:
Years Active: 2013
Title: Jacob Fog Bentzon: Innovator in Atherosclerosis Research
Introduction
Jacob Fog Bentzon is a notable inventor based in Horsens, Denmark. He has made significant contributions to the field of medical research, particularly in the study of atherosclerosis. His innovative work has led to the development of a unique genetically modified pig model that aids in understanding this complex disease.
Latest Patents
Jacob Fog Bentzon holds a patent for a "Pig model for atherosclerosis." This invention relates to a genetically modified pig that serves as a model for studying atherosclerosis. The modified pig displays one or more phenotypes associated with the disease. The patent also discloses a modified pig comprising mutations in the endogenous ApoE gene, LDL gene, LDL receptor gene, or their transcriptional or translational products. Furthermore, the invention includes methods for producing the modified pig, evaluating the effects of therapeutic treatments for atherosclerosis, screening the efficacy of pharmaceutical compositions, and treating individuals suffering from the disease.
Career Highlights
Jacob Fog Bentzon is affiliated with Aarhus Universitet, where he conducts his research and develops his innovative models. His work has garnered attention in the scientific community for its potential to advance the understanding and treatment of atherosclerosis.
Collaborations
Some of his notable coworkers include Charlotte Brandt Sørensen and Peter Michael Kragh. Their collaborative efforts contribute to the ongoing research and development in the field of cardiovascular diseases.
Conclusion
Jacob Fog Bentzon's contributions to atherosclerosis research through his innovative pig model highlight the importance of genetic modifications in medical studies. His work not only enhances the understanding of the disease but also paves the way for potential therapeutic advancements.